Delabelling beta-lactam allergy.

Autor: Molina-Molina GJ; Allergy Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain., Garnica Velandia DR; Allergology Department, Hospital Universitari Santa Maria, Lleida, Spain.; Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRB Lleida), Lleida, Spain., Andrés-López B; Allergy Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain., Perales C; Allergology Section, Hospital de Tortosa Verge de La Cinta, Institut D'Investigació Sanitaria Pere I Virgili, Tortosa, Spain., Marin-Asensio L; Allergology Section, Hospital de Tortosa Verge de La Cinta, Institut D'Investigació Sanitaria Pere I Virgili, Tortosa, Spain., Jurgens Y; Allergy Section, University Hospital Germans Trias I Pujol, Badalona, Spain., Esteso O; Allergy Section, Hospital Universitari Joan XXIII de Tarragona, Tarragona, Spain., Escobar C; Allergy Department, Hospital Universitari Dr. Josep Trueta, Girona, Spain., Vidal X; Clinical Pharmacology Service, Hospital Universitari Vall D'Hebron, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Vendrell L; Clinical Pharmacology Service, Hospital Universitari Vall D'Hebron, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.; Vall D'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Gómez-Ganda L; Pharmacy Department, Hospital Universitari Vall D'Hebron, Barcelona, Spain., Rodríguez D; Clinical Pharmacology Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain., Montané E; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.; Clinical Pharmacology Service, University Hospital Germans Trias I Pujol, Badalona, Spain., Cardona V; Vall D'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Department of Allergy, Hospital Universitari Vall D'Hebron, Barcelona, Spain., Agustí A; Clinical Pharmacology Service, Hospital Universitari Vall D'Hebron, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2024 Jun 27; Vol. 15, pp. 1423719. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year Experience.

Autor: Sala-Cunill A; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; ARADyAL Research Network, Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain; Universitat Autònoma de Barcelona (UAB), Medicine Department, Barcelona, Spain., Molina-Molina GJ; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain., Verdesoto JT; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Labrador-Horrillo M; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; ARADyAL Research Network, Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain; Universitat Autònoma de Barcelona (UAB), Medicine Department, Barcelona, Spain. Electronic address: mlabrador@vhebron.net., Luengo O; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; ARADyAL Research Network, Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain; Universitat Autònoma de Barcelona (UAB), Medicine Department, Barcelona, Spain., Galvan-Blasco P; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain., Guilarte M; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; ARADyAL Research Network, Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain; Universitat Autònoma de Barcelona (UAB), Medicine Department, Barcelona, Spain., Cardona V; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; ARADyAL Research Network, Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Vall d'Hebron Institut de Recerca (VHIR), Immunomediated Diseases and Innovative Therapies, Barcelona, Spain; Universitat Autònoma de Barcelona (UAB), Medicine Department, Barcelona, Spain.

Publikováno v: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Nov; Vol. 9 (11), pp. 4045-4054. Date of Electronic Publication: 2021 Jun 30.

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.

Autor: Navinés-Ferrer A; Biochemistry Unit, Biomedicine Department, Faculty of Medicine, University of Barcelona, Casanova 143, 08036 Barcelona, Spain., Serrano-Candelas E; Biochemistry Unit, Biomedicine Department, Faculty of Medicine, University of Barcelona, Casanova 143, 08036 Barcelona, Spain., Molina-Molina GJ; Biochemistry Unit, Biomedicine Department, Faculty of Medicine, University of Barcelona, Casanova 143, 08036 Barcelona, Spain., Martín M; Biochemistry Unit, Biomedicine Department, Faculty of Medicine, University of Barcelona, Casanova 143, 08036 Barcelona, Spain.

Publikováno v: Journal of immunology research [J Immunol Res] 2016; Vol. 2016, pp. 8163803. Date of Electronic Publication: 2016 Dec 21.

Autosomal recessive hyper‐IgE syndrome due to DOCK8 deficiency: An adjunctive role for omalizumab.

Autor: Nguyen, Kim Han^1,2, Nguyen, Quynh Anh², Tran, Mai Hoang³, Can, Thu Thuy², Vu, Mai Thi², Vo, Nam Sy^3,4, Chi, Hieu Chu⁵, van Nunen, Sheryl^6,7, Van Nguyen, Dinh^1,2 drdinh.allergist@gmail.com

Publikováno v: Journal of Cutaneous Immunology & Allergy. Dec2022, Vol. 5 Issue 6, p222-226. 5p.

Baicalin and lung diseases.

Autor: Sharawi, Zeina W., Ibrahim, Islam M., Abd-alhameed, Esraa K., Althagafy, Hanan S., Jaber, Fatima A., Harakeh, Steve, Hassanein, Emad H. M.

Publikováno v: Naunyn-Schmiedeberg's Archives of Pharmacology; Mar2024, Vol. 397 Issue 3, p1405-1419, 15p